<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40892411</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Mobile App-Based Intervention and Cardiovascular Risk Factors in Patients With Uncontrolled Type 2 Diabetes: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>e2529762</StartPage><MedlinePgn>e2529762</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2529762</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2025.29762</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Controlling modifiable cardiovascular risk factors is important but underused for patients with type 2 diabetes (T2D). Mobile message-based intervention strategies could address this gap but lack evidence of benefit on multiple risk factors.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the effectiveness of a mobile message-based intervention in controlling cardiovascular risk factors in patients with T2D.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">In this randomized clinical trial, adults with uncontrolled T2D comorbid with cardiovascular disease (CVD) risk factors were recruited from 5 clinical centers in China. Data were collected from November 2018 to March 2022 and analyzed from January to June 2023.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="UNASSIGNED">Participants were randomized to receive either usual care or a mobile message-based intervention of 6 text messages per week from different modules designed to remind, encourage, and motivate them to participate in the behaviors needed for improving glycemic control and CVD risk factor management for 12 months.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The primary outcome included mean changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol (LDL-C), and systolic blood pressure (SBP) levels across 12 months. The secondary outcomes included the percentage of participants with controlled HbA1c at 12 months. Data were analyzed using the intention-to-treat principle.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 819 participants (552 men [67.4%]; mean [SD] age, 50.1 [11.9] years; mean [SD] HbA1c level, 10.2% [2.1%]) were enrolled, of whom 410 were randomized to the intervention group and 409 to the control group. During the 12-month intervention, significant reductions in the mobile message-based intervention group were observed for HbA1c levels by -2.8% (95% CI, -2.9% to -2.6%), LDL-C by -11.1 mg/dL (95% CI, -14.7 to -7.4 mg/dL), and SBP by -2.5 mm Hg (95% CI, -3.9 to -1.2 mm Hg), and in the usual care group, by -2.5% (95% CI, -2.7% to -2.3%) for HbA1c, -11.9 mg/dL (95% CI, -15.8 to -8.0 mg/dL) for LDL-C, and -0.1 mm Hg (95% CI, -1.6 to 1.3 mm Hg) for SBP. The net group differences were -0.3% (95% CI, -0.5% to -0.0%) for HbA1c, 0.9 mg/dL (95% CI, -4.5 to 6.2 mg/dL) for LDL-C, and -2.4 mm Hg (95% CI, -4.3 to -0.4 mm Hg) for SBP (P&#x2009;=&#x2009;.001 for the combined overall effect). The percentage of participants with controlled HbA1c among all participants was significantly higher in the intervention group than in the control group at 12 months (195 participants [54.0%] vs 146 participants [46.1%]; P&#x2009;=&#x2009;.04).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">In this randomized clinical trial of adults with uncontrolled T2D in China, a mobile message-based intervention resulted in a modest improvement in HbA1c and SBP in patients with diabetes compared with usual care. These results suggest that mobile message-based strategies for improving glycemic control and CVD risk factors should be considered for adults with T2D.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">ClinicalTrials.gov Identifier: NCT03724526.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Pei-Zhen</ForeName><Initials>PZ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang-Qin</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Fudan University Zhongshan Hospital Xiamen Branch, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian-Fang</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Xu-Zhen</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lin-Jie</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ya-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jun-Feng</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Chun-Min</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Fudan University Zhongshan Hospital Xiamen Branch, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Endocrinology &amp; Metabolism, Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jia-Yang</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chen-Si-Han</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Bing-Yan</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xue-Yun</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>De-Ying</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jun-Lin</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yao-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Yan-Mei</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shi-Qun</ForeName><Initials>SQ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Zhi-Min</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui-Jie</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03724526</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1001/jamanetworkopen.2025.29772</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060145" MajorTopicYN="Y">Text Messaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082742" MajorTopicYN="N">Heart Disease Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40892411</ArticleId><ArticleId IdType="pmc">PMC12406060</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2025.29762</ArticleId><ArticleId IdType="pii">2838316</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Diabetes Federation . IDF Diabetes Atlas. 10th ed. International Diabetes Federation; 2021.</Citation></Reference><Reference><Citation>Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA. 2021;326(24):2498-2506. doi: 10.1001/jama.2021.22208</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.22208</ArticleId><ArticleId IdType="pmc">PMC8715349</ArticleId><ArticleId IdType="pubmed">34962526</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY; China National Diabetes and Metabolic Disorders Study Group . Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012;33(2):213-220. doi: 10.1093/eurheartj/ehr205</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr205</ArticleId><ArticleId IdType="pubmed">21719451</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen PG, Gorter KJ, Stolk RP, Rutten GE. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract. 2009;59(558):43-48. doi: 10.3399/bjgp09X394851</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp09X394851</ArticleId><ArticleId IdType="pmc">PMC2605530</ArticleId><ArticleId IdType="pubmed">19105915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueki K, Sasako T, Okazaki Y, et al. ; J-DOIT3 Study Group . Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(17)30327-3</ArticleId><ArticleId IdType="pubmed">29079252</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-591. doi: 10.1056/NEJMoa0706245</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0706245</ArticleId><ArticleId IdType="pubmed">18256393</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121(6):750-758. doi: 10.1161/CIRCULATIONAHA.109.891523</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.891523</ArticleId><ArticleId IdType="pubmed">20124123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med. 2013;126(10):925.e11-925.e22. doi: 10.1016/j.amjmed.2013.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2013.02.035</ArticleId><ArticleId IdType="pubmed">23810406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1-9. doi: 10.1016/j.diabres.2011.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2011.02.002</ArticleId><ArticleId IdType="pubmed">21382643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez KM. Intrinsic and extrinsic factors affecting patient engagement in diabetes self-management: perspectives of a certified diabetes educator. Clin Ther. 2013;35(2):170-178. doi: 10.1016/j.clinthera.2013.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2013.01.002</ArticleId><ArticleId IdType="pubmed">23411000</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson R, Whittaker R, Pfaeffli Dale L, Maddison R. The effectiveness of text message-based self-management interventions for poorly-controlled diabetes: a systematic review. Digit Health. Published online November 9, 2017. doi: 10.1177/2055207617740315</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2055207617740315</ArticleId><ArticleId IdType="pmc">PMC6001198</ArticleId><ArticleId IdType="pubmed">29942620</ArticleId></ArticleIdList></Reference><Reference><Citation>McCool J, Dobson R, Whittaker R, Paton C. Mobile health (mHealth) in low- and middle-income countries. Annu Rev Public Health. 2022;43:525-539. doi: 10.1146/annurev-publhealth-052620-093850</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-052620-093850</ArticleId><ArticleId IdType="pubmed">34648368</ArticleId></ArticleIdList></Reference><Reference><Citation>Piette JD, List J, Rana GK, Townsend W, Striplin D, Heisler M. Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation. 2015;132(21):2012-2027. doi: 10.1161/CIRCULATIONAHA.114.008723</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.008723</ArticleId><ArticleId IdType="pmc">PMC5234768</ArticleId><ArticleId IdType="pubmed">26596977</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014;63(6):745-54.e6. doi: 10.1016/j.annemergmed.2013.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2013.10.012</ArticleId><ArticleId IdType="pubmed">24225332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255-1263. doi: 10.1001/jama.2015.10945</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.10945</ArticleId><ArticleId IdType="pubmed">26393848</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson R, Whittaker R, Jiang Y, et al. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ. 2018;361:k1959. doi: 10.1136/bmj.k1959</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k1959</ArticleId><ArticleId IdType="pmc">PMC5957049</ArticleId><ArticleId IdType="pubmed">29773539</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortmann AL, Gallo LC, Garcia MI, et al. Dulce digital: an mHealth SMS-based intervention improves glycemic control in Hispanics with type 2 diabetes. Diabetes Care. 2017;40(10):1349-1355. doi: 10.2337/dc17-0230</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-0230</ArticleId><ArticleId IdType="pmc">PMC5606313</ArticleId><ArticleId IdType="pubmed">28600309</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo X, Krumholz HM, Bai X, et al. Effects of Mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circ Cardiovasc Qual Outcomes. 2019;12(9):e005805. doi: 10.1161/CIRCOUTCOMES.119.005805</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.119.005805</ArticleId><ArticleId IdType="pubmed">31474119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson LA, Greevy RA, Spieker A, et al. Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial. Diabetes Care. 2021;44(1):26-34. doi: 10.2337/dc20-0961</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0961</ArticleId><ArticleId IdType="pmc">PMC7783936</ArticleId><ArticleId IdType="pubmed">33154039</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg N, Grabe HJ, Baumeister SE, Freyberger HJ, Hoffmann W. A telephone- and text message-based telemedicine concept for patients with mental health disorders: results of a randomized controlled trial. Psychother Psychosom. 2015;84(2):82-89. doi: 10.1159/000369468</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369468</ArticleId><ArticleId IdType="pubmed">25721861</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi: 10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Ji L, Jia W, et al. ; Chinese Diabetes Society . Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32(5):442-458. doi: 10.1002/dmrr.2827</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.2827</ArticleId><ArticleId IdType="pubmed">27464264</ArticleId></ArticleIdList></Reference><Reference><Citation>Association AD; American Diabetes Association . 4. Lifestyle management: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(suppl 1):S38-S50. doi: 10.2337/dc18-S004</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-S004</ArticleId><ArticleId IdType="pubmed">29222375</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig CL, Marshall AL, Sj&#xf6;str&#xf6;m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395. doi: 10.1249/01.MSS.0000078924.61453.FB</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000078924.61453.FB</ArticleId><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo X, Spatz ES, Ding Q, et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open. 2017;7(12):e018302. doi: 10.1136/bmjopen-2017-018302</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-018302</ArticleId><ArticleId IdType="pmc">PMC5778311</ArticleId><ArticleId IdType="pubmed">29273661</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy J, Lin X, Ryan LM. Scaled marginal models for multiple continuous outcomes. Biostatistics. 2003;4(3):371-383. doi: 10.1093/biostatistics/4.3.371</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/4.3.371</ArticleId><ArticleId IdType="pubmed">12925505</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer HH, Fischer IP, Pereira RI, et al. Text message support for weight loss in patients with prediabetes: a randomized clinical trial. Diabetes Care. 2016;39(8):1364-1370. doi: 10.2337/dc15-2137</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc15-2137</ArticleId><ArticleId IdType="pubmed">26861922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Spatz ES, Bai X, et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circ Cardiovasc Qual Outcomes. 2019;12(4):e005616. doi: 10.1161/CIRCOUTCOMES.119.005616</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.119.005616</ArticleId><ArticleId IdType="pubmed">30998400</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson R, Whittaker R, Jiang Y, et al. Long-term follow-up of a randomized controlled trial of a text-message diabetes self-management support programme, SMS4BG. Diabet Med. 2020;37(2):311-318. doi: 10.1111/dme.14182</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.14182</ArticleId><ArticleId IdType="pmc">PMC7004024</ArticleId><ArticleId IdType="pubmed">31722130</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsahli M, Abd-Alrazaq A, Househ M, Konstantinidis S, Blake H. The effectiveness of mobile phone messaging-based interventions to promote physical activity in type 2 diabetes mellitus: systematic review and meta-analysis. J Med Internet Res. 2022;24(3):e29663. doi: 10.2196/29663</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29663</ArticleId><ArticleId IdType="pmc">PMC8941442</ArticleId><ArticleId IdType="pubmed">35258463</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin C, Courtney KL, Naylor PJ, ERhodes R. Tailored mobile text messaging interventions targeting type 2 diabetes self-management: a systematic review and a meta-analysis. Digital Health. 2019;5. doi: 10.1177/2055207619845279</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2055207619845279</ArticleId><ArticleId IdType="pmc">PMC6481002</ArticleId><ArticleId IdType="pubmed">31041110</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider R, Sudini L, Chow CK, Cheung NW. Mobile phone text messaging in improving glycaemic control for patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;150:27-37. doi: 10.1016/j.diabres.2019.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2019.02.022</ArticleId><ArticleId IdType="pubmed">30822496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou C, Carter B, Hewitt J, Francisa T, Mayor S. Do mobile phone applications improve glycemic control (HbA1c) in the self-management of diabetes? a systematic review, meta-analysis, and grade of 14 randomized trials. Diabetes Care. 2016;39(11):2089-2095. doi: 10.2337/dc16-0346</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-0346</ArticleId><ArticleId IdType="pubmed">27926892</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA;2015;313(6):603-615. doi: 10.1001/jama.2014.18574</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.18574</ArticleId><ArticleId IdType="pubmed">25668264</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258): 405-412. doi: 10.1136/bmj.321.7258.405</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.321.7258.405</ArticleId><ArticleId IdType="pmc">PMC27454</ArticleId><ArticleId IdType="pubmed">10938048</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>